O	0	3	Are
O	4	16	mammographic
O	17	24	changes
O	25	27	in
O	28	31	the
O	32	37	tumor
O	38	41	bed
O	42	46	more
O	47	57	pronounced
O	58	63	after
O	64	78	intraoperative
O	79	91	radiotherapy
O	92	95	for
O	96	102	breast
O	103	109	cancer
O	109	110	?

O	111	119	Subgroup
O	120	128	analysis
O	129	133	from
O	134	135	a
O	136	146	randomized
O	147	152	trial
O	153	154	(
O	154	160	TARGIT
O	160	161	-
O	161	162	A
O	162	163	)
O	163	164	.

O	165	179	Intraoperative
O	180	192	radiotherapy
O	193	194	(
O	194	198	IORT
O	198	199	)
O	200	204	with
O	205	208	low
O	208	209	-
O	209	215	energy
O	216	217	x
O	217	218	-
O	218	222	rays
O	223	225	is
O	226	238	increasingly
O	239	243	used
O	244	246	in
O	247	253	breast
O	253	254	-
O	254	264	conserving
O	265	272	therapy
O	273	274	(
O	274	277	BCT
O	277	278	)
O	278	279	.

O	280	288	Previous
O	289	292	non
O	292	293	-
O	293	303	randomized
O	304	311	studies
O	312	316	have
O	317	325	observed
O	326	338	mammographic
O	339	346	changes
O	347	349	in
O	350	353	the
O	354	359	tumor
O	360	363	bed
O	364	366	to
O	367	369	be
O	370	374	more
O	375	385	pronounced
O	386	391	after
O	392	396	IORT
O	396	397	.

O	398	401	The
O	402	409	purpose
O	410	412	of
O	413	417	this
O	418	423	study
O	424	427	was
O	428	430	to
O	431	439	reassess
O	440	443	the
O	444	457	postoperative
O	458	465	changes
O	466	468	in
O	469	470	a
O	471	481	randomized
O	482	488	single
O	488	489	-
O	489	495	center
O	496	504	subgroup
O	505	507	of
O	508	516	patients
O	517	521	from
O	522	523	a
O	524	535	multicenter
O	536	541	trial
O	542	543	(
O	543	549	TARGIT
O	549	550	-
O	550	551	A
O	551	552	)
O	552	553	.

O	554	556	In
O	557	561	this
O	562	570	subgroup
O	571	572	(
O	572	573	n
O	574	575	=
B-total-participants	576	578	48
O	578	579	)
B-intervention-participants	580	582	27
O	583	591	patients
O	592	600	received
B-intervention	601	604	BCT
I-intervention	605	609	with
I-intervention	610	614	IORT
O	614	615	,
B-control-participants	616	618	21
O	619	627	patients
O	628	631	had
B-control	632	635	BCT
I-control	636	640	with
I-control	641	649	standard
I-control	650	655	whole
I-control	655	656	-
I-control	656	662	breast
I-control	663	675	radiotherapy
O	676	683	serving
O	684	686	as
O	687	695	controls
O	695	696	.

O	697	704	Overall
O	705	708	258
O	709	722	postoperative
O	723	733	mammograms
O	734	735	(
O	735	741	median
O	742	748	follow
O	748	749	-
O	749	751	up
O	752	753	4
O	753	754	.
O	754	755	3
O	756	761	years
O	761	762	,
O	763	768	range
O	769	770	3
O	770	771	-
O	771	772	8
O	772	773	)
O	774	778	were
O	779	794	retrospectively
O	795	804	evaluated
O	805	807	by
O	808	811	two
O	812	824	radiologists
O	825	827	in
O	828	837	consensus
O	838	846	focusing
O	847	849	on
O	850	857	changes
O	858	860	in
O	861	864	the
O	865	870	tumor
O	871	874	bed
O	874	875	.

B-outcome	876	879	Fat
I-outcome	880	888	necroses
O	889	895	showed
O	896	898	to
O	899	901	be
O	902	915	significantly
O	916	920	more
B-outcome	921	929	frequent
O	930	931	(
B-iv-bin-percent	931	933	56
I-iv-bin-percent	933	934	%
O	935	941	versus
B-cv-bin-percent	942	944	24
I-cv-bin-percent	944	945	%
O	945	946	)
O	947	950	and
B-outcome	951	957	larger
O	958	959	(
B-iv-cont-median	959	960	8
I-iv-cont-median	960	961	.
I-iv-cont-median	961	962	7
O	963	969	versus
B-cv-cont-median	970	971	1
I-cv-cont-median	971	972	.
I-cv-cont-median	972	973	6
I-cv-cont-median	974	976	sq
I-cv-cont-median	977	979	cm
O	979	980	,
O	981	987	median
O	987	988	)
O	989	994	after
O	995	999	IORT
O	1000	1004	than
O	1005	1010	those
O	1011	1013	in
O	1014	1022	controls
O	1022	1023	.

B-outcome	1024	1028	Scar
I-outcome	1029	1043	calcifications
O	1044	1048	were
O	1049	1053	also
O	1054	1067	significantly
O	1068	1072	more
O	1073	1081	frequent
O	1082	1087	after
O	1088	1092	IORT
O	1093	1094	(
B-iv-bin-percent	1094	1096	63
I-iv-bin-percent	1096	1097	%
O	1098	1104	versus
B-cv-bin-percent	1105	1107	19
I-cv-bin-percent	1107	1108	%
O	1108	1109	)
O	1109	1110	.

O	1111	1114	The
O	1115	1119	high
B-outcome	1120	1129	incidence
I-outcome	1130	1132	of
I-outcome	1133	1138	large
I-outcome	1139	1142	fat
I-outcome	1143	1151	necroses
O	1152	1154	in
O	1155	1158	our
O	1159	1164	study
O	1165	1173	confirms
O	1174	1182	previous
O	1183	1188	study
O	1189	1197	findings
O	1197	1198	.

O	1199	1206	However
O	1206	1207	,
O	1208	1211	the
O	1212	1219	overall
O	1220	1226	higher
O	1227	1236	incidence
O	1237	1239	of
O	1240	1254	calcifications
O	1255	1257	in
O	1258	1261	the
O	1262	1267	tumor
O	1268	1271	bed
O	1272	1277	after
O	1278	1282	IORT
O	1283	1293	represents
O	1294	1295	a
O	1296	1299	new
O	1300	1307	finding
O	1307	1308	,
O	1309	1318	requiring
O	1319	1326	further
O	1327	1336	attention
O	1336	1337	.
